NDC 31722-277-30 - BUPIVACAINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 31722-277
- Requested NDC
- 31722-277-30
- Package NDCs from labels
- 31722-277-10, 31722-277-31, 31722-277-32, 31722-277-30, 31722-277-33, 31722-277-34
- Manufacturer
- Camber Pharmaceuticals, Inc. | Aspiro Pharma Limited
- Effective date
- 2026-04-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE - Camber Pharmaceuticals, Inc. | Aspiro Pharma Limited | Camber Pharmaceuticals, Inc. | Aspiro Pharma Limited | 2026-04-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 31722-277-10 | BUPIVACAINE HYDROCHLORIDE | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 3 | |
| 31722-277-30 | BUPIVACAINE HYDROCHLORIDE | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 3 | |
| 31722-277-31 | BUPIVACAINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 3 | |
| 31722-277-32 | BUPIVACAINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 3 | |
| 31722-277-33 | BUPIVACAINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 3 | |
| 31722-277-34 | BUPIVACAINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 31722-277-10 | ML - Milliliter | 31722-277 | c4431b8b-8cf0-4f51-9978-fbdcd8bac6f5 | 1 | 2025-03-04 |
| 31722-277-30 | ML - Milliliter | 31722-277 | 26f185f6-83f0-4262-928f-fa71ea28e37c | 1 | 2025-03-04 |
| 31722-277-31 | ML - Milliliter | 31722-277 | d9bc4712-930d-4200-939d-93f4dfe50465 | 1 | 2025-03-04 |
| 31722-277-32 | ML - Milliliter | 31722-277 | 1ac93f5f-001d-4035-bb3c-00200cde715b | 1 | 2025-03-04 |
| 31722-277-33 | ML - Milliliter | 31722-277 | 595d9db0-caf8-4d4c-8010-d778fd54e976 | 1 | 2025-03-04 |
| 31722-277-34 | ML - Milliliter | 31722-277 | d43d409f-d8f1-4edd-9c1a-6129147c6edf | 1 | 2025-03-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc | 3c0f567f-b7f8-4ee8-bfb2-61cd82550498 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1724787 1725078 1725082 1724786 7TQO7W3VT8 |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Sportpharm LLC | a0f9a86f-fa55-4cbb-8273-5dcecd76d627 | 2026-10-10 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Sportpharm LLC | 0e6a55f0-5107-4ea9-9ee1-5c6c09bbe4a6 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 1724880 7TQO7W3VT8 |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Anthea Pharma Private Limited | 4e0cff98-ad0e-494d-8316-b7cdfad6a876 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1725078 1724786 7TQO7W3VT8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.